Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
382,523,969
-
Total 13F shares
-
18,945
-
Share change
-
-890,180,809
-
Total reported value
-
$125,460
-
Price per share
-
$0.33
-
Number of holders
-
6
-
Value change
-
-$301,865,384
-
Number of sells
-
296
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Common Stock (DNA) as of Q3 2024
As of 30 Sep 2024,
RECURSION PHARMACEUTICALS, INC. - Common Stock (DNA) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,945 shares.
The largest 6 holders included
Boston Standard Wealth Management, LLC, Blue Trust, Inc., HOEY INVESTMENTS, INC, IFP Advisors, Inc, ADIRONDACK TRUST CO, and Winch Advisory Services, LLC.
This page lists
6
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.